These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 31420527

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. p38 mitogen-activated protein kinase activation in amygdala mediates κ opioid receptor agonist U50,488H-induced conditioned place aversion.
    Zan GY, Wang Q, Wang YJ, Chen JC, Wu X, Yang CH, Chai JR, Li M, Liu Y, Hu XW, Shu XH, Liu JG.
    Neuroscience; 2016 Apr 21; 320():122-8. PubMed ID: 26826330
    [Abstract] [Full Text] [Related]

  • 3. Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.
    Ehrich JM, Messinger DI, Knakal CR, Kuhar JR, Schattauer SS, Bruchas MR, Zweifel LS, Kieffer BL, Phillips PE, Chavkin C.
    J Neurosci; 2015 Sep 16; 35(37):12917-31. PubMed ID: 26377476
    [Abstract] [Full Text] [Related]

  • 4. Glycogen Synthase Kinase 3β in the Ventral Hippocampus is Important for Cocaine Reward and Object Location Memory.
    Barr JL, Shi X, Zaykaner M, Unterwald EM.
    Neuroscience; 2020 Jan 15; 425():101-111. PubMed ID: 31783102
    [Abstract] [Full Text] [Related]

  • 5. Effects of kappa opioid receptors on conditioned place aversion and social interaction in males and females.
    Robles CF, McMackin MZ, Campi KL, Doig IE, Takahashi EY, Pride MC, Trainor BC.
    Behav Brain Res; 2014 Apr 01; 262():84-93. PubMed ID: 24445073
    [Abstract] [Full Text] [Related]

  • 6. Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning.
    McLaughlin JP, Land BB, Li S, Pintar JE, Chavkin C.
    Neuropsychopharmacology; 2006 Apr 01; 31(4):787-94. PubMed ID: 16123754
    [Abstract] [Full Text] [Related]

  • 7. Different roles of mu-, delta- and kappa-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress.
    Matsuzawa S, Suzuki T, Misawa M, Nagase H.
    Eur J Pharmacol; 1999 Feb 26; 368(1):9-16. PubMed ID: 10096764
    [Abstract] [Full Text] [Related]

  • 8. The role of mu- and kappa-opioid receptors in cocaine-induced conditioned place preference.
    Suzuki T, Shiozaki Y, Masukawa Y, Misawa M, Nagase H.
    Jpn J Pharmacol; 1992 Apr 26; 58(4):435-42. PubMed ID: 1328733
    [Abstract] [Full Text] [Related]

  • 9. Expression and pharmacological modulation of visceral pain-induced conditioned place aversion in mice.
    Bagdas D, Muldoon PP, AlSharari S, Carroll FI, Negus SS, Damaj MI.
    Neuropharmacology; 2016 Mar 26; 102():236-43. PubMed ID: 26639043
    [Abstract] [Full Text] [Related]

  • 10. Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice.
    Skoubis PD, Matthes HW, Walwyn WM, Kieffer BL, Maidment NT.
    Neuroscience; 2001 Mar 26; 106(4):757-63. PubMed ID: 11682161
    [Abstract] [Full Text] [Related]

  • 11. Blockade of morphine reward through the activation of kappa-opioid receptors in mice.
    Funada M, Suzuki T, Narita M, Misawa M, Nagase H.
    Neuropharmacology; 1993 Dec 26; 32(12):1315-23. PubMed ID: 7908722
    [Abstract] [Full Text] [Related]

  • 12. Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice.
    Kuzmin AV, Semenova S, Gerrits MA, Zvartau EE, Van Ree JM.
    Eur J Pharmacol; 1997 Mar 05; 321(3):265-71. PubMed ID: 9085036
    [Abstract] [Full Text] [Related]

  • 13. The long-term effects of stress and kappa opioid receptor activation on conditioned place aversion in male and female California mice.
    Laman-Maharg AR, Copeland T, Sanchez EO, Campi KL, Trainor BC.
    Behav Brain Res; 2017 Aug 14; 332():299-307. PubMed ID: 28625549
    [Abstract] [Full Text] [Related]

  • 14. Sex difference in κ-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[35S]thiotriphosphate) binding in the guinea pig.
    Wang YJ, Rasakham K, Huang P, Chudnovskaya D, Cowan A, Liu-Chen LY.
    J Pharmacol Exp Ther; 2011 Nov 14; 339(2):438-50. PubMed ID: 21841040
    [Abstract] [Full Text] [Related]

  • 15. The kappa opioid receptor agonist U50,488H did not affect brain-stimulation reward while it elicited conditioned place aversion in mice.
    Huang P, Gentile TA, Muschamp JW, Liu-Chen LY.
    BMC Res Notes; 2020 Aug 14; 13(1):384. PubMed ID: 32799930
    [Abstract] [Full Text] [Related]

  • 16. Effects of a newly synthesized kappa-opioid receptor agonist, TRK-820, on the discriminative stimulus and rewarding effects of cocaine in rats.
    Mori T, Nomura M, Nagase H, Narita M, Suzuki T.
    Psychopharmacology (Berl); 2002 Apr 14; 161(1):17-22. PubMed ID: 11967626
    [Abstract] [Full Text] [Related]

  • 17. Intra-accumbens rimonabant is rewarding but induces aversion to cocaine in cocaine-treated rats, as does in vivo accumbal cannabinoid CB1 receptor silencing: critical role for glutamate receptors.
    Ramiro-Fuentes S, Ortiz O, Moratalla R, Fernandez-Espejo E.
    Neuroscience; 2010 May 05; 167(2):205-15. PubMed ID: 20167255
    [Abstract] [Full Text] [Related]

  • 18. Behavioral stress may increase the rewarding valence of cocaine-associated cues through a dynorphin/kappa-opioid receptor-mediated mechanism without affecting associative learning or memory retrieval mechanisms.
    Schindler AG, Li S, Chavkin C.
    Neuropsychopharmacology; 2010 Aug 05; 35(9):1932-42. PubMed ID: 20445500
    [Abstract] [Full Text] [Related]

  • 19. Naltrexone and nalmefene attenuate cocaine place preference in male mice.
    Windisch KA, Reed B, Kreek MJ.
    Neuropharmacology; 2018 Sep 15; 140():174-183. PubMed ID: 30048644
    [Abstract] [Full Text] [Related]

  • 20. Kappa opioid receptor activation potentiates the cocaine-induced increase in evoked dopamine release recorded in vivo in the mouse nucleus accumbens.
    Ehrich JM, Phillips PE, Chavkin C.
    Neuropsychopharmacology; 2014 Dec 15; 39(13):3036-48. PubMed ID: 24971603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.